Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. - Wikidata - wikimedia - TriplyDB

Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology.

Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology.

http://www.wikidata.org/entity/Q38543404

about

Radiotherapy for Non-Hodgkin's lymphoma: still standard practice and not an outdated treatment option Advances in Primary Central Nervous System Lymphoma.Intraocular Lymphoma: Descriptive Data of 26 Patients Including Clinico-pathologic Features, Vitreous Findings, and Treatment Outcomes.Patterns of response and relapse in primary CNS lymphomas after first-line chemotherapy: imaging analysis of the ANOCEF-GOELAMS prospective randomized trial.Patterns of relapse in primary central nervous system lymphoma: inferences regarding the role of the neuro-vascular unit and monoclonal antibodies in treating occult CNS disease.Differential diagnosis of neuromyelitis optica spectrum disorders.Radiation therapy for older patients with brain tumors Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome.Response-adapted treatment with upfront high-dose chemotherapy followed by autologous stem-cell transplantation rescue or consolidation phase high-dose methotrexate for primary central nervous system lymphoma: a long-term mono-center study Partial-brain radiotherapy for primary central nervous system lymphoma: multi-institutional experience.Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing Analyses Prevalence and characteristics of central nervous system involvement by chronic lymphocytic leukemia.Role of microRNAs in primary central nervous system lymphomas.Diagnostic value of using 18F-FDG PET and PET/CT in immunocompetent patients with primary central nervous system lymphoma: A systematic review and meta-analysis.How we diagnose and treat vitreoretinal lymphoma.PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma.Primary Central Nervous System Lymphoma: A Critical Review of the Role of Surgery for Resection.Diagnosis and Management of Leukemic and Lymphomatous Meningitis.Promising treatment results with blood brain barrier disruption (BBBD) based immunochemotherapy combined with autologous stem cell transplantation (ASCT) in patients with primary central nervous system lymphoma (PCNSL).mTORC1 signaling in primary central nervous system lymphoma.Trends in primary central nervous system lymphoma incidence and survival in the U.S.The safety of resection for primary central nervous system lymphoma: a single institution retrospective analysis.Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network.Assessing the Safety of Craniotomy for Resection of Primary Central Nervous System Lymphoma: A Nationwide Inpatient Sample Analysis.Advances in the treatment of newly diagnosed primary central nervous system lymphomas.Efficacy and safety of HD-MTX based systemic chemotherapy regimens: retrospective study of induction therapy for primary central nervous system lymphoma in Chinese.Radiotherapy as an alternative treatment option for primary central nervous system lymphoma patients who are noncandidates for chemotherapy.Balancing relapses versus cognitive impairment in primary central nervous system lymphoma: a single-center experience.High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for pediatric primary central nervous system lymphoma in first complete remission.Role of radiation therapy in primary central nervous system lymphoma : KROG 14-20 Collaborative Study of Brain and Lymphoma Committee.Rituximab, methotrexate, procarbazine, vincristine and intensified cytarabine consolidation for primary central nervous system lymphoma (PCNSL) in the elderly: a LOC network study.Late relapse of primary central nervous system lymphoma.[Malignant lymphomas of the eye].Primary central nervous system lymphoma: Retrospective analysis of 34 cases in a single centre.SLCO1B1 rs4149056 genetic polymorphism predicting methotrexate toxicity in Chinese patients with non-Hodgkin lymphoma.RETRACTED: Primary CNS high-grade B-cell lymphoma, with rearrangements of MYC and BCL6 : a case report.The challenge of adequate imaging surveillance in primary central nervous system lymphoma.Successful rapid drug desensitization to methotrexate in a patient with primary central nervous system lymphoma.TERT promoter mutations in primary central nervous system lymphoma are associated with spatial distribution in the splenium.The diagnosis and treatment of primary vitreoretinal lymphoma: a review.

P2860

Q28079951-1CB78B1E-A299-4285-80E7-B75F47EF9A64 Q31007237-D65F7CA5-CE9D-4EAB-B52D-5C10AA63A523 Q31116141-D297F890-00B4-49A8-B900-5AE21D184472 Q31150088-BF5F6FB2-9DCA-4556-AD09-2A5E5D260B9A Q33759799-96AA95CF-C94B-43EF-886D-BEFC671E1775 Q33812063-840B99C8-8A15-4B13-9EC4-AA3ACBFB8CC1 Q33815025-B1A4E3F3-04ED-45BD-8A33-BF3CE8AE7E8A Q34542980-BF1AE1C1-3FF5-46EE-AB81-D6A085EFB1E3 Q36674028-A8641528-8010-4C4A-98E6-64B3BDB578F4 Q36698034-8E5B8536-312E-4B46-B055-C86A2F4CA181 Q36939219-72609B8E-A59B-45FA-AFC3-DFD5F07EF15E Q37216335-91AA1CC7-4AA1-4DF6-973A-8E88A34AD6A6 Q38779730-DEF44FC5-6038-4AC8-ABD1-DCFAF858587B Q38780459-DA357AB1-AA2F-47D2-A73D-3A733BEF74E9 Q38822438-1DEFF716-3DDB-45B1-9022-A3CC32FCE8DB Q38868430-2CD5ACF1-9D3E-40DA-8A98-66CE8E324A5B Q38940715-9A8938EE-1EC7-429F-8EFE-DBADA669A0D3 Q39126738-839AD171-9274-4330-A464-81B769878CC4 Q39279101-11D3A26F-B7D7-40D3-B019-8DDB4F929944 Q39501076-5FE5DE71-0743-420D-AFB9-6DC28A4EA764 Q39886553-2CB33FC7-6407-4F3C-B10E-EB74ADAC5CEF Q40367193-34FEAE3E-C345-4F11-9D6C-1BAC44345375 Q41139081-AF755CD0-AC86-4F34-B372-5B61D81DCE20 Q41684323-CF9270CE-AC83-454F-B8A1-ED8BEDCDC21F Q42377771-378CDED3-1F2F-46ED-9EBC-5ABA08F73F11 Q47136050-4D179021-02B5-4466-883D-BE05E61129A8 Q47145424-264972EE-DC50-43F9-A3E4-0DD317B340C3 Q47907052-65FD0B71-EC95-421B-A301-B6A54CCC3197 Q48100602-303093F8-0D12-474F-A9A9-B29711B24FB4 Q48100638-0B3B294F-32E1-41EA-BF83-D2D57FBE612D Q48246102-B4AC9802-B4F3-4071-A95A-1B8A6A7C88E1 Q48631019-84AFE6F6-9EF4-4733-9FB1-0D059F9818D3 Q49376021-356BC2DB-BBBF-4E0F-A4AA-C3D40BE21658 Q49564968-062E99AF-5D30-4FFE-8E70-025360825363 Q50220996-9A37A60D-8A15-4D00-BEDA-4BE4160F289D Q52718896-FF7583AE-68BF-454C-BA20-67E68911C304 Q52843442-ABF175A5-EC94-4B3D-9E99-7A6A2923B5BF Q53073383-79738487-2179-4DD6-9D43-3BC4AA34DEB4 Q53415990-826BF7EB-025D-4A3D-9B63-17C916270585 Q55005388-FD3E49D0-678F-4375-A5CB-F9FB75081DAE

P2860

Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology.

http://www.wikidata.org/entity/Q38543404

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Diagnosis and treatment of pri ...... ssociation for Neuro-Oncology.

@en

type

label

Diagnosis and treatment of pri ...... ssociation for Neuro-Oncology.

@en

prefLabel

Diagnosis and treatment of pri ...... ssociation for Neuro-Oncology.

@en

P1433

Q38543404-87946FAD-D4C5-41F5-A8FE-113E676F1F6B

P1476

Q38543404-CCEF9E6B-8E2E-4F5F-8608-0B26656866DB

P2093

Q38543404-0AD8B905-DBFA-40C4-AE79-AD6AEA9E7B09

Q38543404-0D5153C8-C09C-42A4-AC38-A38ED90436E8

Q38543404-10117C74-888C-4587-9CD2-53E5F69B801A

Q38543404-1BEE4578-C29E-49B5-9434-452FA31FF5B2

Q38543404-1C79AC51-47E5-4CCE-AF17-A558ACF894C1

Q38543404-28B348E2-4E7F-41FD-A702-F02E3011EF42

Q38543404-3675EE52-AEA4-4D98-A84B-104B910C2BEF

Q38543404-43C6E652-45BC-44C3-BAE8-985B25D2B1A5

Q38543404-4CA8DA95-A3F8-4A17-AD14-9F04DD612C2B

Q38543404-4D3247A3-4CF4-450D-8A19-0E970F61B5BB

P304

Q38543404-8F331B83-8270-41D4-A687-0EA712334243

P31

Q38543404-B1493CA6-F738-4020-A630-0A8B94CC1197

P356

Q38543404-4740A2D0-0E0A-48EA-A19B-90AF1A29FA86

P433

Q38543404-9C71C010-1993-40BB-A7D5-1ECE6F9A63F5

P478

Q38543404-BB2B9AE6-0DF8-4FCD-9F6C-D76DCADF8801

P50

Q38543404-4FB53E5A-42A2-45F9-8153-11FE7B05B6C0

Q38543404-5CB29E79-2F16-4CD5-BFCB-2AE5F01772B1

P577

Q38543404-A0678B76-06ED-4148-9D60-5C0F89610F64

P698

Q38543404-F612E55E-DCC9-4C92-8CC4-B99F7A65AB30

P356

S1470-2045(15)00076-5

P1433

The Lancet Oncology

P1476

Diagnosis and treatment of pri ...... ssociation for Neuro-Oncology.

@en

P2093

Andreas F Hottinger

http://www.w3.org/2001/XMLSchema#string

Andrés J M Ferreri

http://www.w3.org/2001/XMLSchema#string

Carole Soussain

http://www.w3.org/2001/XMLSchema#string

Clemens M F Dirven

http://www.w3.org/2001/XMLSchema#string

Eric Bessell

http://www.w3.org/2001/XMLSchema#string

European Association for Neuro-Oncology Task Force on Primary CNS Lymphoma

http://www.w3.org/2001/XMLSchema#string

Francesc Graus

http://www.w3.org/2001/XMLSchema#string

Jacoline Bromberg

http://www.w3.org/2001/XMLSchema#string

Khê Hoang-Xuan

http://www.w3.org/2001/XMLSchema#string

Martin Taphoorn

http://www.w3.org/2001/XMLSchema#string

P304

e322-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1470-2045(15)00076-5

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Matthias Preusser

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26149884

http://www.w3.org/2001/XMLSchema#string